Recombinant Human RPL17 Protein, N-His

Description of Recombinant Human RPL17 Protein, N-His

Introduction

The study of proteins is essential in understanding the molecular mechanisms of life. Proteins are responsible for various biological processes, including catalyzing reactions, transporting molecules, and providing structural support. Recombinant proteins, produced through genetic engineering techniques, have become valuable tools in both research and industrial applications. One such recombinant protein is the Recombinant Human RPL17 Protein, which has gained attention for its unique structure, diverse activities, and potential applications.

Structure of Recombinant Human RPL17 Protein

The Recombinant Human RPL17 Protein, also known as Ribosomal Protein L17, is a component of the 60S ribosomal subunit in eukaryotic cells. It is encoded by the RPL17 gene located on chromosome 22 in humans. The protein is composed of 157 amino acids with a molecular weight of approximately 18 kDa. It has a conserved primary structure, with a high degree of sequence similarity among different species. The crystal structure of the protein has been determined, revealing its unique three-dimensional shape.

Activity of Recombinant Human RPL17 Protein

The primary function of RPL17 is to participate in the translation process, where it helps in the assembly of the ribosome and facilitates the decoding of mRNA into proteins. It also plays a role in the regulation of gene expression and cellular growth. Recent studies have shown that RPL17 has additional activities, including DNA binding and RNA chaperone function. These activities have been linked to the protein’s ability to interact with various cellular components, such as DNA, RNA, and other proteins.

Applications of Recombinant Human RPL17 Protein

The unique structure and diverse activities of Recombinant Human RPL17 Protein make it a valuable tool in various applications. One of its main uses is in the production of recombinant proteins. RPL17 is essential for the proper functioning of the ribosome, and its absence can lead to defects in protein synthesis. Therefore, the addition of recombinant RPL17 can improve the efficiency and yield of protein production in heterologous expression systems.

Another potential application of RPL17 is in the development of diagnostic tools. The protein has been identified as a potential antigen in autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis. Antibodies against RPL17 have been detected in the serum of patients with these diseases, making it a potential biomarker for diagnosis.

Furthermore, RPL17 has been studied as a potential target for cancer therapy. It has been found to be overexpressed in certain types of cancer, and its knockdown has been shown to inhibit cancer cell growth. Recombinant RPL17 can be used in drug screening assays to identify potential inhibitors of its activity, which could lead to the development of new cancer treatments.

Conclusion

In conclusion, Recombinant Human RPL17 Protein is a versatile molecule with a unique structure and diverse activities. Its role in protein synthesis, gene expression, and potential applications in protein production, diagnostics, and cancer therapy make it a valuable tool in the field of biotechnology. Further research on this protein and its interactions with other cellular components may reveal even more potential applications, making it an exciting area of study in the scientific community.